Last but not least, the statins-metform in association could be the winning strategy also in preventing cancer development in healthy women with high mammographic breast density, that is, women whose breasts have a high stroma component often associated with the infiltration of aromatase-overexpressing macrophages, and for this reason at risk of developing breast cancer. This evidence concerns the gene CYP19A1 and breast cancer.